Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;62(4):595-604.
doi: 10.20471/acc.2023.62.04.3.

THE ROLE OF PLASMA COPEPTIN LEVEL IN DETERMINING THE SEVERITY AND MORTALITY OF SUBARACHNOID HEMORRHAGE

Affiliations

THE ROLE OF PLASMA COPEPTIN LEVEL IN DETERMINING THE SEVERITY AND MORTALITY OF SUBARACHNOID HEMORRHAGE

Seda Ozkan et al. Acta Clin Croat. 2023 Dec.

Abstract

The study aimed to investigate the role of plasma copeptin level in setting the diagnosis, severity and mortality of patients with subarachnoid hemorrhage (SAH) admitted to the emergency department. We included patients aged ≥18 years who were diagnosed with SAH. Blood samples were collected from patients at the time of admission to the emergency department for assessment of plasma copeptin levels. The Glasgow Coma Scale (GCS), World Federation of Neurological Surgeons (WFNS), modified Fisher score, in-hospital mortality and one-year mortality rates were determined in patients. There was a statistically significant difference in plasma copeptin levels between the patients (mean: 0.78±0.41 ng/mL) and healthy controls (mean: 0.48±0.27 ng/mL) (p=0.001). There was no significant correlation of plasma copeptin levels with the GCS, WFNS, and modified Fisher scores. There was no significant difference in copeptin levels between the patients who died in the hospital (mean: 0.73±0.42 ng/mL) and those who did not (mean: 0.80±0.41 ng/mL) (p=0.41). Although plasma copeptin level may be used in the diagnosis of SAH, it does not have a role in determining the patient condition severity and mortality.

Keywords: Copeptin; Emergency department; Mortality; Subarachnoid haemorrhage.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Comparison of plasma copeptin levels in SAH patients and healthy controls. SAH = subarachnoid hemorrhage
Fig. 2
Fig. 2
Comparison of copeptin levels, GCS, WFNS and modified Fisher scores relative to in-hospital mortality. GCS = Glasgow Coma Score; WFNS = World Federation of Neurological Surgeons
Fig. 3
Fig. 3
Comparison of copeptin levels, GCS, WFNS and modified Fisher scores relative to one-year mortality. GCS = Glasgow Coma Score; WFNS = World Federation of Neurological Surgeons

References

    1. Galea J, Ogungbenro K, Hulme S, Patel H, Scarth S, Hoadley M, et al. Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the subcutaneous interleukin-1Ra in SAH (SCIL-SAH) study. J Neurosurg. 2018;128:515–23. Epub 2017 Feb 24.10.3171/2016.9.JNS16615 - DOI - PubMed
    1. Doerfler S, Faerber J, McKhann GM, Elliott JP, Winn HR, Kumar M, et al. The incidence and impact of secondary cerebral insults on outcome after aneurysmal subarachnoid hemorrhage. World Neurosurg. 2018;114:e483–94. Epub 2018 Mar 21.10.1016/j.wneu.2018.02.195 - DOI - PubMed
    1. Hackman JL, Nelson AM, Ma OJ. Spontaneous subarachnoid and intracerebral hemorrhage. In: Tintinalli JE, Stapczynski JS, Ma OJ, Yealy DM, Meckler GD, Cline DM (eds). Emergency Medicine A Comprehensive Study Guide. 8th edn. New York: The Mc Graw Hill Companies, 2016; pp. 1137-41.
    1. Novaković N, Lepić M, Minić L, Radenović K, Rotim A, Rasulić L. Combined treatment of ruptured middle cerebral artery aneurysm followed by subarachnoid hemorrhage and acute subdural hematoma in multiple aneurysm disease of cerebral blood vessels: case report. Acta Clin Croat. 2016;55:659–62. 10.20471/acc.2016.55.04.19 - DOI - PubMed
    1. Pačić-Turk L, Jandrijević P, Havelka-Meštrović A. Recovery of memory after cerebral artery aneurysm surgery. Acta Clin Croat. 2019;58:229–39. 10.20471/acc.2019.58.02.05 - DOI - PMC - PubMed

LinkOut - more resources